BERLIN, September 13 /PRNewswire-FirstCall/ -- The stockholders of Schering AG (NYSE: SHR - News) have assembled today, Wednesday, in Berlin for an Extraordinary Stockholders' Meeting, at which outgoing Management Board Chairman Dr. Hubertus Erlen has appealed for their consent to the domination and profit and loss transfer agreement with Bayer subsidiary Dritte BV GmbH. Also on the agenda are elections to the Supervisory Board to reflect Schering's new ownership structure. Bayer holds more than 95 percent of the outstanding shares of the Berlin-based pharmaceutical company. The stockholders will also resolve on the announced renaming of Schering AG to "Bayer Schering Pharma Aktiengesellschaft."
